VASO

VASOMEDICAL INC

VASO

Overview Fund Activity

Delisted

VASO was delisted on the 25th of May, 2006.

Back to rankings

Healthcare Medical Devices

Financial journalist opinion

Zacks Investment Research

Vaso Stock Down Following Q2 Earnings as Revenue and Margins Fall

VASO reports a second-quarter 2025 loss as lower imaging deliveries and rising costs pressured revenue and profit margins.

Vaso Stock Down Following Q2 Earnings as Revenue and Margins Fall

Zacks Investment Research

Vaso Stock Slips Post Q1 Earnings Despite Record Revenue Growth

VASO's first-quarter 2025 revenues hit a record high, but a narrowed net loss and muted stock reaction highlight investor caution despite solid segment growth.

Vaso Stock Slips Post Q1 Earnings Despite Record Revenue Growth

Vaso Corporation Announces Financial Results for First Quarter of 2025

PLAINVIEW, N.Y., May 15, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales services, and proprietary medical products, today announced its operating results for the three months ended March 31, 2025.

Vaso Corporation Announces Financial Results for First Quarter of 2025

Zacks Investment Research

VASO Stock Rises Post Q4 Revenue Growth and Solid Segment Gains

Vaso's fourth-quarter 2024 results reflect record revenue and strong segment growth despite a decline in full-year profit due to higher operating expenses.

VASO Stock Rises Post Q4 Revenue Growth and Solid Segment Gains

CORRECTION - Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2024

PLAINVIEW, N.Y., March 31, 2025 (GLOBE NEWSWIRE) -- Please note that, in a release issued under the same headline earlier today by Vaso Corporation (OTCQX: VASO), some figures in the written description of the financial results for the three months and the full year were misstated.

CORRECTION - Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2024

Vaso Corporation Announces Executive Leadership Appointments & Names New Vice Chairman to the Board of Directors

PLAINVIEW, N.Y, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leader in human capital, information technology and MedTech, today announced new executive appointments to the Vaso management team and Board of Directors, effective January 1, 2025.

Vaso Corporation Announces Executive Leadership Appointments & Names New Vice Chairman to the Board of Directors

Vaso Corporation CEO Reflects on a Year of Growth and Innovation in End-of-Year Letter Setting the Tone for a Promising 2025

Vaso Corporation 137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 NEWS RELEASE PLAINVIEW, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leader in human capital, information technology and MedTech, today released a letter to shareholders and employees summarizing the company's achievements throughout the year and outlining key strategic developments and priorities for the upcoming year.

Vaso Corporation CEO Reflects on a Year of Growth and Innovation in End-of-Year Letter Setting the Tone for a Promising 2025

Zacks Investment Research

VASO Stock Up Despite Q3 Earnings Decline and Rising Costs

Vaso posts third-quarter 2024 revenue growth, but higher costs and a net loss affect profitability.

VASO Stock Up Despite Q3 Earnings Decline and Rising Costs

Vaso Corporation Announces Financial Results for Third Quarter 2024

PLAINVIEW, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading medtech company with a diversified business portfolio in network and healthcare IT services, professional sales services, and proprietary medical products, today reported its operating results for the three months ended September 30, 2024.

Vaso Corporation Announces Financial Results for Third Quarter 2024

Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I

PLAINVIEW, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO) today announced that it has provided notice to Achari Ventures Holdings Corp. I (“Achari”) to terminate the Business Combination Agreement with Achari. The Company will continue to seek opportunities to increase stockholder value, including through internal growth, new partnerships, and strategic investments with a concentration on medical and IT service companies.

Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I

See News Rankings

Charts implemented using Lightweight Charts™